Transcarent is planning to acquire Accolade for $621 million, the companies announced Wednesday. The two companies are very complementary and the deal gives Accolade a chance to turn things around after struggling in the public market, experts say.
In the latest episode of the MedCity News Pivot Podcast, Heather Cox, President of Insights & Empowerment at Zelis, shared how the company works with health plans to communicate with members to help them make proactive healthcare decisions.
Neuroflow acquired Intermountain Health's behavioral health risk analytics model to integrate into its software platform. The model identifies which patients may be at risk of experiencing mental health crises so that care teams can step in to provide timely support.
Galapagos said the planned business separation will leave the legacy company free to focus on developing cell therapies for cancer. An accompanying corporate restructuring will shave Galapagos's headcount by 40%.
Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread adoption of artificial intelligence technologies and the IPO market's return to normal levels.
Certified clinicians and therapists have specific ethical foundations and analytic responsibilities to uphold that might not apply to all members of the healthcare field.
Dr. Shantanu Nundy describes how care navigation company Accolade can help self-insured employers lower costs for providing health coverage to their employees.
No comments